Opus Genetics, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-57.3% -$3M
$-9M
Free Cash Flow↓-57.3% -$3M
$-9M
Investing Cash Flow↓-100.0% -$1M
$0
Financing Cash Flow
$24M
Stock Buybacks
—
Stock-Based Comp↓-2.6% -$21K
$774K
Debt Issued
—
D&A↑+30.0% +$3K
$13K
SBC Allocated Expense↓-2.6% -$21K
$774K
SBC Unrecognized Cost↓-6.8% -$500K
$7M